The largest database of trusted experimental protocols

1260 infinity 2 hplc system

Manufactured by Agilent Technologies
Sourced in United States, Italy

The 1260 Infinity II HPLC system is a high-performance liquid chromatography instrument designed for reliable and efficient separation and analysis of a wide range of chemical compounds. It provides precise control of solvent delivery, temperature regulation, and detection capabilities to support various analytical applications.

Automatically generated - may contain errors

56 protocols using 1260 infinity 2 hplc system

1

HPLC Analysis of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
An Agilent 1260 Infinity II HPLC system equipped with a UV detector (Agilent Technologies, Santa Clara, CA, USA) was employed for the analysis. Separations were carried out on an InfinityLab Poroshell 120 EC-C18 reverse phase HPLC column (4.6 × 100 mm I.D., particle size 2.7 μm, Agilent Technologies) at 28 °C. The mobile phases were (A) 0.02 M aqueous ammonium acetate–acetonitrile (90:10, v/v) and (B) 100% acetonitrile. The pH of solvent A was adjusted to 5.0 with glacial acetic acid. All solutions were prepared with HPLC-grade reagents and were degassed before use. For HPLC separation, the flow rate was 0.5 mL/min with constant 100% solution A for 2 min, followed by a gradient from 100% solution A to 100% solution B over an 8 min time course. The absorbance of the elution was monitored at 280 and 295 nm.
+ Open protocol
+ Expand
2

Globin Chain Analysis by RP-HPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
RP-HPLC assays were performed on an Agilent 1260 Infinity II HPLC system with Diode Array Detector (32 (link),33 (link)). The chromatographic column is Aeris™ 3.6 μm WIDEPORE XB-C18 200 Å, LC Column 250 × 4.6 mm behind a securityGuard™ ULTRA cartridge (Phenomenex). Solvent A: 0.1% trifluoroacetic acid in HPLC grade water at pH 2.9. Solvent B: acetonitrile. The linear gradient developed from 41% of solvent B to 47% of solvent B to separate and analyze the various globin chains.
+ Open protocol
+ Expand
3

HPLC Analysis of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HPLC analysis was conducted on an Agilent 1260 Infinity II HPLC system equipped with a binary pump, an autosampler, a thermostated column compartment, and a diode array detector (Agilent Technologies, Santa Clara, CA, USA). The compounds were separated on a Waters Atlantis® T3-C18 column (4.6 × 50 mm, 5 μm, Waters™, MA, USA) at 28 °C. The mobile phase consisted of 0.04% aqueous formic acid (A) and methanol (B) using a gradient program of 20–25% (B) in 0–13 min, 25–35% (B) in 13–20 min, and 35% (B) in 20–25 min. The flow rate was 1.0 mL min−1. The detection wavelength was 240 nm.
+ Open protocol
+ Expand
4

Quantitative Analysis of Medicinal Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
One gram of LR powder was accurately weighed and placed in a 50 mL conical flask. Then 20 mL of methanol solution was added for 30 min ultrasonic extraction, and the liquid was cooled and weighed. Swertiamarin (2 mg), sweroside (1 mg), hesperetin (1 mg), coumarin (4.9 mg), 1.7-dihydroxy-3,8-dimethoxyl xanthone (1 mg), and 1-hydroxy-2,3,5 trimethoxanthone (1 mg) were carefully weighed and put into a 10 mL flask, dissolved in methanol and diluted to scale, shaken well, and filtered through a 0.45 µm microporous filter membrane (each 1 mL contained 0.2 mg swertiamarin, 0.1 mg sweroside, 0.1 mg hesperidin, 0.49 mg coumarin, 0.1 mg 1,7-dihydroxy-3,8-dimethoxone, and 0.1 mg 1-hydroxy-2,3,5-trimethoxone). High performance liquid chromatography (HPLC) analysis was performed on an Agilent 1260 InfinityII HPLC system. ZORBAX SB-C18 5-Micron column (4.6 mm × 250 mm) with mobile phase water (A) - 0.1% phosphate aqueous solution (B) and gradient elution (0-15 min, 30%-35% B; 15 to 25 min, 35%-50% B; 25 to 35 min, 50%-65% B; 35 to 45 min, 65%-70% B; 45 to 50 min, 70%-80% B; 50 to 55 min, 80%-95%; 55-60 min, 95%-100%). The flow rate was set to 1.0 mL/min, the column temperature was set to 30 °C, and the detection wavelength was set at 234 nm. Standards of six compounds were purchased (Sigma-Aldrich, St. Louis, MO, United States), and calibration curves were performed.
+ Open protocol
+ Expand
5

HPLC Analysis of Phytochemical Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used an Agilent Technologies 1260 Infinity II HPLC system (Agilent Technologies, Waldbronn, Germany) equipped with a VWD detector (λ = 280 nm) to perform the HPLC analysis of extracts and fractions. The flow rate was 0.8 mL/min using a Supelco Analytical HS-C18 (Supelco Analytical, Bellefonte, PA, USA). The column (3 μm, 4.6, 75 mm) was thermostated at 30 °C. The mobile phase consisted of 1% aqueous acetic acid (A) and acetonitrile containing 1% acetic acid (B). The following gradient steps were programmed: 0–2 min—10% B, 2–4 min—10–20% B, 4–21 min—20–30% B, 21–26 min—30–40% B, 26–31 min—40–50% B, 31–34 min—50–90% B, and 34–36 min—90–50% B. The data were analyzed using OpenLab CDS software v. 2.4 (Agilent Technologies, Waldbronn, Germany).
+ Open protocol
+ Expand
6

Quantification of Auxin Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantification of auxin metabolites was performed according to the method described by Novák et al. [60 (link)]. Approximately 10 mg of root or shoot tissue were homogenized and extracted with 1 mL of cold 50 mM sodium-phosphate buffer (pH 7.0) containing 0.1% sodium diethyldithiocarbamate and mixture of internal standards containing 5 pmol of [2H4]ANT, [2H5]IAM, [2H4]IPyA, [13C6]IAA, [13C6]oxIAA, [13C6]IAA-Asp, [13C6]IAA-Glu, [13C6]IAA-Glc, [13C6]oxIAA-Glc and 25 pmol of [2H5]Trp and [2H4] IAN. After centrifugation at 36000 g for 10 min, one-half of each sample was acidified with 1 M HCl to pH 2.7 and purified by solid-phase extraction (SPE) using the Oasis™ HLB columns (30 mg, 1 mL; Waters, Milford, MS, USA). For quantification of IPyA, the second half of the sample was derivatized with cysteamine (0.25 M, pH 8.0) for 1 h, acidified with 3 M HCl to pH 2.7, and purified by SPE. After evaporation under reduced pressure, the auxin content of the samples was analyzed using the 1260 Infinity II HPLC system (Agilent Technologies, CA, USA) equipped with a Kinetex C18 (50 mm × 2.1 mm, 1.7 μm; Phenomenex). The LC system was linked to a 6495 Triple Quad Detector (Agilent Technologies, USA).
+ Open protocol
+ Expand
7

Size-Exclusion Chromatography of Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analytical SEC was performed using an Agilent 1260 Infinity II HPLC System equipped with a Superdex 200 Increase 5/150 GL column coupled to a multi-angle light scattering system (DAWN HELEOS-II, Optilab T-rEX, and Eclipse DualTec - Wyatt Technologies). For all experiments, 10 µL of protein at a concentration of 1 mg/mL in PBS was injected onto the column. Chromatograms were processed using Astra 7.3 (Wyatt Technologies).
+ Open protocol
+ Expand
8

Synthesis of GzmB Substrate Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
FITC-labelled GzmB substrate peptides ((FITC)AIEFDSGc; lower case letters = d-form amino acids) were synthesized by Tufts University Core Facility and used for in vivo formulations. FITC-labelled GzmB substrate peptides with internal quencher ((5-FAM)aIEFDSG(K-CPQ2)kkc) were synthesized by CPC Scientific and used for all in vitro activity assays. Quenched fluorescent peptides for screening candidate substrates ((5-FAM)-{substrate}-(K-DABCYL)-amide)) were synthesized by Genscript or in-house, as described below. Mass-barcoded peptides for multiplexed urinary monitoring (eGVndneeGFFsAr(ANP)GG-{substrate}-GGC, ANP = 3-amino-3-(2-nitrophenyl)propionic acid) were synthesized in-house using the Liberty Blue Peptide Synthesizer (CEM). The peptide synthesis scale used was 0.025 mmol, and low-loading rink amide resin (CEM) was used. Amino acids (Chem-Impex) were resuspended in DMF (0.2 M), as were all synthesis buffers. Activator buffer used was diisopropylcarbodiimide (DIC; Sigma) (0.25 M) and the activator base buffer was Oxyma (0.25 M; CEM) while the deprotection buffer was piperidine (20% v/v; Sigma) supplemented with Oxyma (0.1 M). Crude peptides were purified on 1260 Infinity II HPLC system (Agilent) until a purity of 80% was achieved. Peptide mass and purity were validated by LC-MS (Agilent) and Autoflex MALDI-TOF mass spectrometer (Bruker).
+ Open protocol
+ Expand
9

Quantitative Analysis of Globin Chains in Erythroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analysis of globin chains in CD34+-cell-derived erythroblasts was performed by reverse-phase HPLC, as previously described48 (link),49 (link). In brief, the reverse-phase HPLC assay was carried out on an Agilent 1260 Infinity II HPLC system with Diode-Array Detector. The chromatographic column used was an Aeri 3.6-μm WIDEPORE XB-C18 200-Å, LC Column 250 × 4.6 mm2 behind a securityGuard ULTRA cartridge (Phenomenex). Globin chains were separated using a gradient program of 41–47% solvent B (acetonitrile) mixed with solvent A (0.1% trifluoroacetic acid in HPLC-grade water at pH 2.9), and quantified by the area under the curve (AUC) of the corresponding peaks in the reverse-phase HPLC chromatogram.
+ Open protocol
+ Expand
10

HPLC Quantification of Lumefantrine

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lumefantrine was quantified with a 1260 Infinity II HPLC system (Agilent Technologies, Santa Clara, CA) with a reversed-phase C18 column (ZORBAX Eclipse Plus, 5 μm particle size, 4.6 mm × 150 mm, Agilent Technologies, Santa Clara, CA) maintained at 25 °C. The mobile phase comprised 70% MeCN and 30% acidified water (0.1% TFA). The isocratic elution mode with a flow rate of 1.5 mL/min was used. For each analysis, the injection volume was 80 μL and lumefantrine was detected at 335 nm using an ultraviolet detector. With these conditions, the retention time of lumefantrine was ∼4.8 min.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!